Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab

Research output: Contribution to journal › Article › Academic › peer-review

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{ed00fb3157ba41db9d0d1068b6ebc355,

title = "Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab",

author = "Milan Sonneveld and {Darwish Murad}, Sarwa and {Baltissen - van der Eijk}, Annemiek and {de Man}, Rob",

year = "2019",

doi = "10.14309/crj.0000000000000243",

language = "Undefined/Unknown",

volume = "6",

journal = "ACG Case Reports Journal",

issn = "2326-3253",

publisher = "American College of Gastroenterology",

number = "12",

}

TY - JOUR

T1 - Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab

AU - Sonneveld, Milan

AU - Darwish Murad, Sarwa

AU - Baltissen - van der Eijk, Annemiek

AU - de Man, Rob

PY - 2019

Y1 - 2019

U2 - 10.14309/crj.0000000000000243

DO - 10.14309/crj.0000000000000243

M3 - Article

C2 - 32042838

SN - 2326-3253

VL - 6

JO - ACG Case Reports Journal

JF - ACG Case Reports Journal

IS - 12

M1 - e00243

ER -